Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults

被引:0
|
作者
Charache, S [1 ]
机构
[1] JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:15 / 21
页数:7
相关论文
共 50 条
  • [2] Pharmacokinetic and pharmacodynamic of hydroxyurea in adults with sickle cell anemia
    Sassi, H.
    Bachir, D.
    Habibi, A.
    Blanchet, B.
    Astier, A.
    Galacteros, F.
    Hulin, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 88 - 88
  • [3] Hydroxyurea for sickle cell anemia
    Bachmeyer, Claude
    Aractingi, Selim
    Lionnet, Francois
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (01): : 98 - 98
  • [4] Proportion of Adults With Sickle Cell Anemia and Pain Crises Receiving Hydroxyurea
    Stettler, Nicolas
    McKiernan, Colleen M.
    Melin, Court Q.
    Adejoro, Oluwakayode O.
    Walczak, Nancy B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (16): : 1671 - 1672
  • [6] Hydroxyurea for the treatment of sickle cell anemia
    Platt, Orah S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (13): : 1362 - 1369
  • [7] Hydroxyurea therapy for sickle cell anemia
    McGann, Patrick T.
    Ware, Russell E.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (11) : 1749 - 1758
  • [8] Impact of Hydroxyurea on Perioperative Management and Outcomes in Children With Sickle Cell Anemia
    Hayashi, Masanori
    Calatroni, Agustin
    Herzberg, Brittany
    Ross, Allison K.
    Rice, Henry E.
    Thornburg, Courtney
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (07) : 487 - 490
  • [9] Hydroxyurea (HU) is associated with reduced mortality in adults with sickle cell anemia.
    Steinberg, MH
    Barton, F
    Castro, O
    Ramirez, G
    Bellevue, R
    Terrin, M
    BLOOD, 2000, 96 (11) : 485A - 485A
  • [10] HYDROXYUREA AS TREATMENT FOR SICKLE-CELL-ANEMIA
    CHARACHE, S
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (03) : 571 - 583